BWX Technologies combines established naval nuclear demand with growth from commercial nuclear and microreactors, making it one of the most obvious buys today. Nuclear components and fuel for US submarines and aircraft carriers carry the business, with real contracts, profits, growing revenue and little reliance on speculative announcements. Guidance is up and backlog has grown, which looks better at a lower price. The premium valuation is worth paying as the next wave of nuclear demand builds. … Show more

BWX Technologies is one of the only US companies cleared to build nuclear parts at the precision and security level the government requires. It manufactures reactor components and nuclear fuel assemblies for the US Navy and commercial reactor builders alike. Anyone can design reactors, but someone still has to physically build the parts, and almost no one else in the country is cleared to do it. x.com 

BWX Technologies looks expensive against its earnings. Fair value runs $81.12-$103.24, and the valuation leans on forecasts, with forward earnings 35% above trailing; the price sits 37% above the top of that range. Forward P/E is 27x and PEG 1.67. This is a levels-only read off reported earnings and revenue estimates, with no fundamental work. x.com 

BWX Technologies is the best nuclear play because its business is built on government contracts. @cfromhertz, in the post quoted, notes a weekly chart at new highs in a rough cup-and-handle pattern. x.com 

US nuclear stocks such as Centrus Energy and BWX Technologies could see a resurgence because electricity is by far AI's most important bottleneck. BloombergNEF now expects 118GW of US data-center capacity by 2030, 52% above its prior forecast, yet that is 63GW short of what planned AI chip shipments would need. BWX also gains from the Navy's $76 billion submarine award to General Dynamics and Huntington Ingalls, as a key subcontractor. Nuclear stocks have been hit hard after early AI gains. … Show more

Nuclear stocks like Cameco, Centrus, BWX Technologies, Constellation, Vistra, Talen, Oklo and NuScale are exposed because pro-nuclear sentiment can reverse for a decade or two, and investors who started after Fukushima have only seen the pro phase. The US never built a central waste site, so spent fuel sits on-site in dry casks, at San Onofre barely 100 feet from the Pacific. An earthquake, corrosion or a disaster anywhere, under any design, could turn the public against nuclear again. x.com  … Show more

Nuclear is the always-on energy source that looks pricey but is far more competitive on true cost per delivered watt, making Oklo, NuScale, X-Energy, Denison Mines and BWX Technologies one of the main ways to play the energy transition, alongside solar and batteries. x.com 

BWX Technologies is a company of the future, with bets on a positive future such as Kinectrics building a tritium loop facility in the UK for fusion reactors. The stock is expensive, but the chart shows a bullish ascending triangle, and a break above $220 is the signal to watch; a deep break of the lower trendline would be unwelcome. Look beyond the thin veil of negativity. x.com 

The suppliers beneath the big nuclear deals going to Constellation Energy and Vistra get paid while the utilities get the headlines. GE Vernova supplies nuclear equipment, turbines and grid gear; Cameco uranium, fuel and Westinghouse technology; Centrus US enrichment and HALEU for the coming SMR boom; BWX Technologies nuclear components and reactor manufacturing. Oklo is an SMR developer and future fuel customer, while Fluor and Quanta Services add construction and power-infrastructure exposure. … Show more

Nuclear stocks could create generational wealth for early investors, with six names covering different parts of the build-out. Vistra sells existing nuclear power, including 1,200 MW to AWS from Comanche Peak for 20 years. Oklo's small reactors run on spent fuel. Cameco sells uranium and owns 49% of Westinghouse. BWX Technologies is among the few firms cleared to build nuclear parts. NuScale holds the first US SMR design approval yet trades under $9. Centrus has a $3 billion enrichment backlog. … Show more